News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Medicine Recall – Marevan® (Warfarin) 3mg Tablets

Medicine Recall – Marevan® (Warfarin) 3mg Tablets (Blue)


Recall of Marevan® (warfarin) 3mg tablets (blue)
GlaxoSmithKline New Zealand (GSK), in consultation with Medsafe, is recalling all Marevan (warfarin) 3mg tablets (blue) dispensed to patients since 23 November 2009.
Marevan® is an anticoagulant treatment used widely in New Zealand to thin blood to help prevent blood clots. Marevan® 3mg tablets are blue in colour.
The recall is due to a manufacturing problem that could mean that a limited number of the Marevan® (warfarin) 3mg tablets (blue) may contain more medicine than the labelled amount.

If a patient has taken a Marevan ® (warfarin) 3mg tablet (blue) from the affected batch, it may place the patient at an increased risk of bruising and/or bleeding. Signs of increased anticoagulant activity include abnormal bleeding or bruising, vomiting with the appearance of coffee grounds or blood, blood in the urine or stool, or black tarry stools.
Patients who have received their Marevan® 3mg tablets (blue) after 23 November 2009 are advised to:

1. Not suddenly stop taking this treatment.

2. Seek advice and replacement tablets as soon as possible.

3. Return the Marevan® (warfarin) 3mg tablets (blue) to their pharmacy for free replacement, if required.

4. Contact the doctor or clinic that prescribed their medicine for advice on whether further testing or monitoring is required.

5. Contact their doctor immediately if any ill effects are noticed.


GSK is working with doctors and pharmacists to contact any patients who may be affected by this batch recall.
“Patient safety is our first concern and the results of our investigations to date give us confidence that this is an isolated incident. If patients have any concerns about their medication, they should discuss these with their pharmacist or their health practitioner,” said Geoff McDonald, General Manager at GSK New Zealand.
Marevan® (warfarin) is available in three different strengths – 1mg (brown), 3mg (blue) and 5mg (pink). This recall only affects the Marevan® (warfarin) 3mg tablets (blue) and does not affect any other batches or strengths, or any other GSK products.

GSK sincerely regrets any inconvenience and is confident that supply to customers will not be affected by this recall activity.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Bodega: Venue Closing At The End Of The Year, After 25 Years Of Music

"It is with considerable sadness that, for reasons beyond our control, we regret to announce the closure of Bodega’s doors at the end of this year, after 25 years of faithful and committed service to live music in Wellington." More>>

Memorabilia: Te Papa Buys Peter Snell Singlet

Te Papa has purchased the singlet worn by Peter Snell at the 1964 Tokyo Olympics at an auction this morning at Cordy’s auction house in Auckland. More>>

ALSO:

Scoop Review Of Books: Women At The Centre

In the first chapter of her epic History of New Zealand Women, Barbara Brookes places a version of the Māori creation story alongside that of the Pākehā colonists, setting the scene for how each society saw women. The contrast is startling. More>>

In Auckland Art Gallery: A Tour Of Duty

I had already started my journey through the exhibited collections when an audio announcement about a guided tour to embark shortly from the foyer was made, I decided to join in. Why not? More>>

Art: ‘Holiday’ Wins IHC Art Awards

An intricate embroidered cushion by Wellington artist Jo-Anne Tapiki has won the 2016 IHC Art Awards and $5000. Jo-Anne started working from IHC’s Arts on High studio in Lower Hutt 18 months ago and this is the first time she has entered the competition. More>>

‘Quasi’: Christchurch Art Gallery Reveals Rooftop Sculpture

Christchurch-born and internationally renowned artist Ronnie van Hout has had a huge hand in Christchurch Art Gallery's latest outdoor installation. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news